Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.145 -0.235 (-3.68%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Q1 2020 Adaptive Biotechnologies Corp Earnings Call Transcript

May 12, 2020 / 08:30PM GMT
Release Date Price: $38.06 (-0.16%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies First Quarter Financial Results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Carrie Mendivil, Investor Relations. Please go ahead, ma'am.

Carrie Mendivil
Gilmartin Group LLC - Principal

Thank you. Earlier today, Adaptive Biotechnologies released financial results for the first quarter ended March 31, 2020. If you have not received this news release, or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected]. Like most of you, many of us are working from home, so please bear with us if we encounter any unforeseen audio issues with today's call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot